Ofs Capital Corporat (OFS) 13.79 $OFS OFS Capital

New Post Public Reply Private Reply Replies (0) Message Board

Sep 2, 2016 at 11:24 PM

Ofs Capital Corporat (OFS) 13.79 $OFS

OFS Capital Corporation Announces Second Quarter Financial Results
BusinessWire - Fri Aug 05, 7:00AM CDT
--Second Quarter Net Investment Income of $0.36 Per Share
OFS: 13.79 (-0.01)

Finance Stocks' Q2 Earnings Slated on Aug 5: AINV, OFS, WHF
Zacks Equity Research - Zacks Investment Research - Thu Aug 04, 6:40AM CDT
Global growth concerns and low interest rate environment continue to adversely impact the companies' performance.
WHF: 11.57 (+0.01), AINV: 6.09 (-0.02), OFS: 13.79 (-0.01)

American Capital (ACAS) Q1 Earnings Beat on Lower Costs
Zacks Equity Research - Zacks Investment Research - Mon May 09, 7:54AM CDT
American Capital, Ltd. (ACAS) reported first-quarter 2016 net operating income per share of 31 cents, beating the Zacks Consensus Estimate of 25 cents.
SFE: 14.26 (+0.33), ACAS: 17.05 (+0.13), AINV: 6.09 (-0.02), OFS: 13.79 (-0.01)

OFS Capital posts 1Q profit
Automated Insights - Fri May 06, 7:06AM CDT
CHICAGO (AP) _ OFS Capital Corp. (OFS) on Friday reported first-quarter earnings of $2.3 million.
OFS: 13.79 (-0.01)

OFS Capital Corporation Announces First Quarter Financial Results
BusinessWire - Fri May 06, 7:00AM CDT
--First Quarter Net Investment Income of $0.38 Per Share Increased 32% Year-Over-Year
OFS: 13.79 (-0.01)

OFS Capital Corporation Announces Date for Its First Quarter 2016 Earnings Release and Conference Call
BusinessWire - Tue Apr 26, 7:00AM CDT
OFS Capital Corporation (NASDAQ:OFS) ("OFS Capital"

, a business development company, announced today that, prior to the opening of the stock market on Friday, May 6, 2016, it will issue a press release announcing its first quarter 2016 earnings results.
OFS: 13.79 (-0.01)

Beat the Market with Low Beta Stocks
Zacks Equity Research - Zacks Investment Research - Thu Apr 14, 3:31PM CDT
A low beta strategy helps in identifying stocks that are less volatile than the market.
FDP: 58.94 (+0.57), OFS: 13.79 (-0.01), SBGL: 16.27 (+0.21), TAST: 13.79 (+0.40)

American Capital (ACAS) Buys Back Shares Worth $296.5M
Zacks Equity Research - Zacks Investment Research - Mon Apr 04, 1:20PM CDT
American Capital Ltd. (ACAS) announced the repurchase of its common stock worth $296.5 million. The company bought back a total of 21.2 million shares of its common stock at an average price of $13.96 per share.
SFE: 14.26 (+0.33), ACAS: 17.05 (+0.13), BKCC: 8.83 (+0.14), OFS: 13.79 (-0.01)

The Zacks Analyst Blog Highlights: OFS Capital, Carnival, Navios Maritime Acquisition, Sibanye Gold and Gilead Sciences
Zacks Equity Research - Zacks Investment Research - Tue Dec 29, 8:30AM CST
The Zacks Analyst Blog Highlights: OFS Capital, Carnival, Navios Maritime Acquisition, Sibanye Gold and Gilead Sciences
CCL: 46.39 (-2.31), GILD: 76.89 (-0.53), NNA: 1.49 (+0.04), OFS: 13.79 (-0.01), SBGL: 16.27 (+0.21)

5 Play-It-Safe Stocks for 2016
Swarup Gupta - Zacks Investment Research - Mon Dec 28, 8:18AM CST
Several key market watchers signal higher volatility continuing into next year.
CCL: 46.39 (-2.31), GILD: 76.89 (-0.53), NNA: 1.49 (+0.04), OFS: 13.79 (-0.01), BAC: 16.00 (+0.02), SBGL: 16.27 (+0.21)

Can OFS Capital (OFS) Stock Continue to Grow Earnings?
Zacks Equity Research - Zacks Investment Research - Fri Dec 04, 7:39AM CST
OFS Capital (OFS) seems well-positioned for future earnings growth and it is seeing rising earnings estimates, coupled with a solid Zacks Rank
OFS: 13.79 (-0.01)

OFS Capital Corporation Announces Third Quarter 2015 Financial Results
BusinessWire - Fri Nov 06, 7:00AM CST
--Net investment income of $0.38 per share increased 25% year over year
OFS: 13.79 (-0.01)

OFS Capital Corporation Announces Date for Its Third Quarter 2015 Earnings Release and Conference Call
BusinessWire - Fri Oct 23, 10:00AM CDT
OFS Capital Corporation (NASDAQ: OFS), a business development company (BDC), announced today that, prior to the opening of the stock market on Friday, November 6, 2015, it will issue a press release announcing the Company's third quarter 2015 earnings results.
OFS: 13.79 (-0.01)

OFS Capital Corporation Announces Second Quarter 2015 Financial Results
BusinessWire - Fri Aug 07, 7:00AM CDT
--New Originations and Portfolio Optimization Drive 126 Basis Point Increase in Average Yield of Portfolio to 11.50%
OFS: 13.79 (-0.01)

OFS Capital Corporation Announces Date for Its Second Quarter 2015 Earnings Release and Conference Call
BusinessWire - Fri Jul 24, 7:00AM CDT
OFS Capital Corporation (NASDAQ:OFS), a business development company (BDC), announced today that, prior to the opening of the stock market on Friday, August 7, 2015, it will issue a press release announcing the Company's second quarter 2015 earnings results.
OFS: 13.79 (-0.01)

OFS Capital Corporation Realizes Gain on Sale of Equity Investment in Convene
BusinessWire - Wed Jun 17, 7:00AM CDT
OFS Capital Corporation (NASDAQ:OFS) announced today that it has realized a $1.5 million, or $0.16 per share, gain on the sale of its equity investment in one of its portfolio companies, Convene, the nation's fastest growing network of urban meeting centers and integrated workplace amenity services, as part of a recently completed growth equity financing round for the company. OFS Capital Corporation continues to support Convene as a lender.
OFS: 13.79 (-0.01)

OFS Capital Corporation Sells $67.3 Million in Lower-Yielding Senior Loans above First Quarter Aggregate Fair Value
BusinessWire - Tue Jun 02, 7:00AM CDT
OFS Capital Corporation (NASDAQ:OFS), a business development company specializing in meeting the capital needs of middle market borrowers, announced today that on May 28, 2015, it sold the majority of its lower-yielding senior club loan portfolio for approximately $67.3 million to Madison Capital Funding LLC. This sale price is approximately $0.6 million higher than the March 31, 2015 aggregate fair value of the loans sold, as reported in OFS Capital Corporation's quarterly SEC filings.
OFS: 13.79 (-0.01), WFC: 50.55 (+0.12)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Gaine Expands Healthcare Data Solutions Ahead of HLTH 2026

Ever felt like healthcare systems are still stuck in a bygone era, struggling with data flinging through the void? Well, Gaine Technology is throwing down its gauntlet to change that narrative. Successful in pharmaceuticals and life sciences, they're turbocharging their Consent and Preference Management solution across the vast, tangled web of healthcare markets just in...

Innovent's Seven Drugs Leap onto 2026 Reimbursement Chart

A Bold Move in Biopharmaceuticals Innovent Biologics just pulled a rabbit out of their hat. Seven of their cutting-edge meds made it onto China's National Reimbursement Drug List for 2026. This isn't just a spreadsheet entry—it's a lifeline thrown to patients across the oncology, metabolic, and autoimmune landscapes, as well as a financial booster for Innovent (HKEX:...

El Pollo Loco Faces Class Action Over Wage Practices

Alright, here's where things start sizzling—El Pollo Loco, the fast-food chicken chain whose name translates to 'The Crazy Chicken'—is in a legal pickle. The lawsuit hanging over their heads could spell a sticky situation for them and possibly ripple through the fast-food industry. The suit, filed by the steadfast firm Blumenthal Nordrehaug Bhowmik De Blouw LLP, has...

HiTHIUM Joins Cambridge to Boost Global Energy Storage

HiTHIUM and Cambridge's New Energy Venture There's a big splash coming out of Xiamen, folks. HiTHIUM, a heavyweight in the energy storage sector, has decided to team up with the University of Cambridge. They inked a deal aiming to bridge the academic ivory tower with industrial grit, focusing on long-duration energy storage. It was all sealed during the Global Energy...

Ecopetrol Sidesteps Hefty Fines After Investigation Closure

Colombian Watchdog Gives Ecopetrol a Pass It's like dodging a bullet in a duel at high noon. The Superintendency of Industry and Commerce (SIC) has finally closed its investigation into Ecopetrol S.A. and its subsidiaries, CENIT and OCENSA, after a probe two years in the making. The stakes were sky-high, folks. We're talkin' about just shy of 530 billion Colombian pesos...

Webull Faces Class Action: Key Details for Investors

What's Really Going on With Webull? When you hear there's a class-action lawsuit brewing, you know something's gone real sideways. Webull Corporation (NASDAQ: BULL) finds itself neck-deep in a securities fraud class action alleging some dicey dealings with China. If you've got skin in the game—and if you bought Webull stock between April 26, 2025, and October 6,...

Greenberg Traurig's Brad Kaufman: A Mentor of Resolute Impact

A Milestone for Mentorship at Greenberg Traurig In the often cutthroat jungle of law, finding someone who actually gives a damn about you is as rare as finding a unicorn. Yet, there it is—Brad Kaufman, at the helm of Greenberg Traurig's professional development, proving that mentorship can be more than just a checkbox on a quarterly review. Award for Exceptional...

Fluence Energy Faces Leadership Departures Amid Legal Woes

Fluence Energy's Rocky Road Continues It's chaos once again in the halls of Fluence Energy (NASDAQ:FLNC). The ship seems to drift further from solid ground as their CEO and CFO candidly decided to jump ship, shaking investor confidence even more vigorously. The market's reaction was swift and brutal: a nasty 9% share drop, leaving investors with more than just a headache....

CARsgen's CAR-T Breakthrough on China's Insurance List

A Game Changer for CAR-T Therapies There's a breeze of optimism blowing from Shanghai these days—a rare sensation in this market of endless skirmishes. CARsgen Therapeutics Holdings Limited, a company entrenched in the development of cutting-edge CAR T-cell therapies, just notched a victory. They've announced that their CAR T-cell therapy product, satricabtagene...

AppLovin Legal Woes: A Deep Dive into Investor Claims

AppLovin Faces Legal Heat and Market Scrutiny Bitter truth has a way of crashing like a wave, and AppLovin (NASDAQ: APP) is feeling the brunt of it. Now knee-deep in a securities class action, the firm’s been accused of selling fairy tales about its AI capabilities, leaving investors clutching at substantial losses. If you’ve been banking on their promises between...